Drug shortages in the US are a growing crisis, members of Congress were told last Friday, September 23. And there is no single reason why this is happening and no easy solutions to the problem.
Problems lie mostly in older generic versions of sterile injectable drugs, which are low-priced and
- complicated to manufacture
- made by a only a few companies
- manufactured in aging plants where quality is hard to maintain.